semaglutide tablets novo nordisk Details of failed studies cast pall on Nordisk's GLP-1 as Alzheimer's treatment More than 170,000 people in

At Boon Aesthetics, weve witnessed how this innovative solution transforms lives not just bodies

Weeks 9 through 12: Momentum Phase By the three-month mark, cumulative results tend to be significant

PMID: 110 Di RosaCAltomareATerrignoVCarboneFTackJCicalaMet al

GLP-1 Market Share, By Indication, 2025 (%) The obesity and weight management segment held a 28% share of the market in 2025 and is expected to grow at the fastest CAGR of 18.6% during the projection period

Supports Heart, Lung, and Circulatory Health*

As access to compounded GLP-1 injections recently became increasingly restricted, many patients turned to the gray market an underground network where medications are sold outside regulated pharmacies